HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Small dense low-density lipoprotein in familial combined hyperlipidemia: Independent of metabolic syndrome and related to history of cardiovascular events.

AbstractINTRODUCTION:
It is unclear whether small dense low-density lipoprotein (sdLDL) are associated with familial combined hyperlipidemia (FCHL), independently of the metabolic syndrome (MS). It is also unclear whether sdLDL are related to history of cardiovascular (CVD) events in FCHL patients, independently of MS.
PATIENTS AND METHODS:
Serum levels of sdLDL, expressed as percentage of total LDL cholesterol (LDL score), were determined in 137 probands with FCHL and in 133 normolipidemic, normotensive, normoglycemic healthy subjects.
RESULTS:
In binary logistic regression age- and gender-adjusted LDL score values above the 90th and 95th percentiles of the values in the control group (10.23 and 13.11%, respectively) were found to be significant predictors of FCHL status, independently of MS diagnosis (p=0.007 and p<0.0001, respectively). Values of the LDL score above the 90th and the 95th percentile of the control group resulted to be significantly related to FCHL status, even after adjustment for the components of MS (p=0.006 and p=0.001, respectively). Among FCHL patients, values of the LDL score above 95th percentile of the values in the control group were found to be significantly related to personal and/or family history of CVD events, independently of age, gender, total cholesterol, apolipoprotein (apo) B, and MS status (p=0.016). The same significant relationship was found adjusting for all components of MS (p=0.034).
CONCLUSIONS:
High concentrations of sdLDL are highly specific markers of FCHL, independently of concomitant MS. In FCHL patients high levels of sdLDL are related to history of CVD events, independently of MS, total cholesterol and apo B.
AuthorsPaolo Pauciullo, Marco Gentile, Gennaro Marotta, Angela Baiano, Stefania Ubaldi, Fabrizio Jossa, Gabriella Iannuzzo, Fulvio Faccenda, Salvatore Panico, Paolo Rubba
JournalAtherosclerosis (Atherosclerosis) Vol. 203 Issue 1 Pg. 320-4 (Mar 2009) ISSN: 1879-1484 [Electronic] Ireland
PMID18760784 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Biomarkers
  • Cholesterol, LDL
Topics
  • Adult
  • Aged
  • Biomarkers
  • Cardiovascular Diseases (blood, diagnosis)
  • Case-Control Studies
  • Cholesterol, LDL (metabolism)
  • Female
  • Humans
  • Hyperlipidemia, Familial Combined (blood)
  • Male
  • Metabolic Syndrome (blood)
  • Middle Aged
  • Prognosis
  • Regression Analysis

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: